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Abstract
Introduction: Differences in Gleason grade in transrectal ultrasonography 
(TRUS) biopsies and radical prostatectomy (RP) specimens are well 
documented in literature. Keeping in view the limitations of Gleason grading 
system, Epstein JI grade group system was introduced. Various other 
parameters also have a significant role in predicting the pathological stage, 
extraprostatic extension, status of surgical margins and metastatic disease 
in regional lymph nodes. RP is performed at limited centres in Pakistan. Till 
date, no comparison of the histopathological findings in 12-core TRUS and 
RP specimens had been performed at the national level. Our study is aimed at 
generating local data in this context. Materials and Methods: This was a cross-
sectional study and non-probability consecutive sampling was performed. It 
was conducted at Histopathology Department, Shifa International Hospital, 
Islamabad, from January 2008 to December 2014. Gleason scores of 20 
RP specimens were compared to Gleason scores of TRUS biopsies of same 
patients. Concordance in Gleason score and grade groups with laterality, 
perineural invasion was also studied. Results: Out of 20 RP cases, 40% (n = 
8) had a Gleason score of 6, 30% (n = 6) had score 7, 20% (n = 4) had score 
8 and 15% (n = 3) had score 9. Compared to the TRUS biopsy, RP Gleason 
score was concordant in 11 cases (55%), higher in 7 cases (35%) and lower in 
2 cases (10%). TRUS involvement was unilateral in 10 cases (50%) and bilateral 
in 10 cases (50%). However, bilateral involvement of RP specimen was seen in 
14 cases (70%) and unilateral in 6 cases (30%). Thus, better tumour yield was 
observed in RP specimens i.e., bilateral involvement in RP specimens was 
found in additional 5 cases (25%). Perineural involvement was higher in RP 
specimen i.e., 12 cases (60%), compared to 5 cases (25%) in TRUS biopsies. 
Its concordance was significantly higher in those with Gleason score of equal 
to or more than 7 (83%) and low in score less than score 7 (17%). Conclusion: 
When comparing RP to initial TRUS biopsies, Gleason score was upgraded 
in 35% and downgraded in 10% of cases. Bilateral involvement in 25% of 
cases of RP specimens was underestimated as unilateral involvement in TRUS 
biopsies. Perineural involvement with high Gleason score was also seen.
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Gleason grade importance is known for several 
decades in prostatic adenocarcinoma.[1] It is 
accepted as an important parameter in decision-
making of therapy. Grade 8 or above is a strong 
predictive of lymph node involvement. In such 
cases, pelvic lymphadenectomy or frozen section 
before radical prostatectomy (RP) can be planned.[2]
Gleason grading system is solely based on the 
architecture of tumour cells. Prediction of Gleason 
score in RP specimens by needle core biopsies 
improves with 18-gauge needle biopsies and more 
number of cores. Correlation is still not ideal in all 
cases and undergrading is a particular problem, in 
up to 58% of cases.[3]
Differences in Gleason grade in transrectal 
ultrasonography (TRUS) biopsies and RP specimens 
are well documented in literature. In addition to the 
above-mentioned reasons, another important area 
of difficulty was to quantify percentages of Gleason 
pattern Grades 3 and 4 when they are admixed. 
It is important to make a distinction between 
them. Gleason scores 3 + 4 and 4 + 3 are clinically 
distinct.[4] There are also differences in tumour 
laterality as predicted by TRUS biopsy. Significant 
discordance is observed in low-grade tumour as 
compared to high-grade tumours. It is important 
because a high-grade tumour is associated 
with more extensive disease in the prostate and 
has significant potential to spread outside the 
prostate.[1] In cases with low-grade disease at initial 
TRUS biopsies, it had been recommended that 
treating surgeon should take into account the other 
clinical parameters and limitations of TRUS biopsy 
in assessing the Gleason score.[5]
Keeping in view the limitations of Gleason 
grading system, Epstein JI grade group system 
was introduced. It is now formerly accepted and 
published in the World Health Organization 
Classification of Tumours of the Urinary System 
and Male Genital Organs 4th  Edition, Volume 8 
in 2016.[6] Univariate and multivariate statistical 
analyses were performed to assess the grade 
grouping system to estimate its implication and 
were found to be independently related with 
increased risk of prostate cancer-related mortality 
within 15 years of follow-up. Patients with grade 
groups  3–5 significantly progressed to cancer-
specific death.[7]
In the grade group system, score begins from 
3 + 3 = 6. Patterns defined as 3 and 4 are more 
clearly defined.[6] Total Gleason score 6 which is 
grade Group 1 is considered a relatively indolent 
disease. Total Gleason scores 3 + 4 and 4 + 3 are 
segregated in grade Groups 2 and 3 as they have 
different prognosis while total Gleason scores 8 
and 9–10 are grouped under grade Groups 4 and 
5, respectively, which are associated with worse 
prognosis.[6]
Clinical management of prostate cancer has 
evolved significantly so has the grading system 
of prostate carcinoma. These changes in grading 
will facilitate the clinicians to better deal with these 
patients. At present, Gleason score and grade 
groups are to be reported simultaneously in each 
report to make the pathologists and clinicians 
well versed with this new system. With time, they 
will be able to directly use grade group without 
mentioning Gleason score.[6]
Various other parameters also have a significant role 
in predicting the pathological stage, extraprostatic 
extension, status of surgical margins and metastatic 
disease in regional lymph nodes. These include 
the percentage of tumour in TRUS biopsy and 
perineural invasion (PNI).[8] If tumour is >50% in 
any core or >50% of TRUS biopsy, then there is 
an increased possibility of detecting high-risk 
pathological findings in RP specimens.[9] Extended 
prostate biopsy scheme had significantly improved 
the precision and correlation between Gleason 
score in TRUS biopsy and RP.[10]
Tumour volume estimate is also quite challenging, 
particularly in the setting of multiple positive sites. 
It is critical to decide which of the data is more 
predictive of final tumour volume and hence in 
clinical decision-making.[4]
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RP is performed at limited centres in Pakistan. 
Till date, no comparison of the histopathological 
findings in 12-core TRUS and RP specimens had 
been performed at the national level. Our study 
is aimed at generating local data in this context. 
The objective of this study was to determine the 
correlation between histopathological features 
of prostatic adenocarcinoma in transurethral 
ultrasound-guided (TRUS) biopsy with RP 
specimens.
Materials and Methods
This study analysed 20  patients who underwent 
RP with or without neoadjuvant hormonal therapy 
(NHT) for prostate cancer between January 2008 
and June 2014 at Shifa International Hospital, 
Islamabad. All patients irrespective of age were 
included in the study. All patients had positive TRUS 
core biopsy. Gleason grading system and Epstein JI 
grade grouping were utilised for grading.[6] Tumour 
volume in a positive TRUS biopsy was defined 
as the percentage of areas of biopsy cores 
involved by carcinoma and was visually estimated. 
RP specimens were examined and processed 
according to standardised protocols. Gleason 
score, laterality, tumour volume, PNI, extraprostatic 
extension, seminal vesicle invasion, status of lymph 
nodes if dissected and final pathological staging 
were also recorded.
Gleason scores of TRUS biopsies were compared 
with the respective Gleason scores of RP specimens. 
Concordance in Gleason score, laterality, tumour 
volume and PNI on TRUS biopsies with Gleason 
score, laterality, tumour volume, extraprostatic 
extension and pathological staging was performed.
Results were analysed by statistical software SPSS 
version 20. Mean was calculated for age and PSA. 
Frequency and percentages were calculated 
for primary Gleason grade, secondary Gleason 
grade, total Gleason score, grade group, tumour 
volume, PNI, laterality, extraprostatic extension 
and pathological staging in both specimens. 
Concordance was performed for Gleason score, 
grade group and tumour volume, PNI of TRUS 
biopsies with Gleason score, grade group, tumour 
volume, PNI, extraprostatic extension, surgical 
margins and pathological staging of RP specimens.
Results
Out of 20 RP cases, 40% (n = 8) had a Gleason 
score of 6, 30% (n = 6) had score 7, 20% (n = 4) 
had score 8 and 15% (n = 3) had score 9 [Figure 1]. 
Compared to the TRUS biopsy, RP Gleason score 
was concordant in 55%, higher in 35% and lower in 
10%. One of the cases could not be graded due to 
scanty nature of tumour after NHT [Figures 2 and 3].
Eight cases fall in grade Group 1, 4 in grade Group 2, 
2 in grade Group 3, 4 in grade Group 4 and 3 in 
grade Group 5. Unilateral involvement was initially 
reported in 10 cases on TRUS biopsies. However, 
during analysis of RP specimens, four cases were 
Figure 1: Comparison of Gleason score in transrectal 
ultrasonography and radical prostatectomy specimens
Figure  2: (a) Transrectal ultrasonography showing 
small glands lined by cuboidal to columnar epithelium 
and perineural invasion, grade  Group  1. (b) Radical 
prostatectomy specimen of same patient showing 
grade Group 1
ba
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upstaged because of bilateral involvement. All 
10 cases with bilateral tumour on TRUS biopsies 
showed similar findings in RP specimens.
PNI was higher in RP specimen i.e., in 60% (n = 12) 
of cases, compared to 25% (n = 5) in TRUS biopsies 
with high concordance in those with Gleason score 
of ≥7 (83%).
EPE was seen in 35% (n = 7). About 43% (n = 3) of 
these had Gleason score of 8, while both scores 9 and 
7 were 28% (n = 2) [Figure 5]. All of these cases had 
PNI.
Pathological tumour stage showed concordance 
with Gleason score, PNI and EPE. Out of eight cases 
of Gleason score 6, one was pT1 and seven were 
pT2. Majority of cases with Gleason score 7 and 
above i.e., 10 out 12 (40%) were pT3 while 1 case of 
Gleason score 7 and 8 fall in pT2. All three cases of 
Gleason score 9 were pT3. All T3 cases showed EPE.
NHT was given in 40% (n = 8) and showed disease 
confinement to organ in 87% with negative surgical 
margins.
Discussion
RP is the usual treatment of high-grade prostatic 
adenocarcinoma. Various factors such as Gleason 
grade group, Gleason score, pathologic stage, 
margin status, PNI and tumour volume predict the 
long-term prognosis.[11]
Prostate needle biopsy findings provide key 
information to plan treatment.[9] Sextant biopsy 
schemes were traditionally used to predict 
the above-mentioned important prognostic 
features in RP specimens. However, these 
had poor correlation with  prostatectomy 
Gleason scores.[11] Extended 12-core biopsy has 
significantly improved prostate cancer detection 
and precision of Gleason score.[11,12] Various 
studies have highlighted different reasons for 
significant discordance between the Gleason 
score in core biopsies and RP specimens. These 
include pathological interpretation bias and 
sampling effects like number of core biopsies.[5,12] 
Hence, it is important for clinicians to consider 
various other clinical parameters and limitations 
of core biopsy.[5]
Figure  4:  Per ineural  invasion in  t ransrectal 
ultrasonography and radical prostatectomy specimens
Figure 5: Results of extracapsular involvement in various 
Gleason scores
Figure  3: (a) Transrectal ultrasonography biopsy of a 
patient showed fused glands in majority of cores and 
some spaced glands were also seen. Grade  Group  3 
was assigned. (b) Radical prostatectomy specimen of 
same patient showed predominantly Gleason score 3, 
final grade group was 2
ba
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Undergrading of tumour in the needle biopsy, 
with a higher Gleason score in the matched RP 
specimens, is the most common problem. Prior 
studies have reported undergrading in 27–72% of 
cases [Table 1].[2,5,9,13,14] They mentioned that most 
of such cases were of low grade and probable 
reasons attributed to this were number of biopsy 
cores, procedure, prostate volume and lack of 
specialist expertise at the reporting centre.[2,5,9,13,14] 
In our study, 35% of cases showed higher grade 
in RP specimens. In a study by Pinthus et al., 
approximately half of tumours graded Gleason 
score 6 at biopsy were found to have Gleason 
score 7 in RP specimens. Upgraded Gleason 
score 6–7 tumours have outcomes similar to those 
of genuine Gleason score 7 carcinoma. Hence, 
authors recommended that for Gleason score 6 
carcinomas in prostate biopsy, clinicians should 
judge the overall likelihood of tumour upgrading 
as well as specific patient characteristics, such as 
prostate-specific antigen and the percentage of 
tumour (tumour volume) in the prostate biopsy 
when contemplating options that are optimised 
for low-grade tumours including observation or 
brachytherapy.[15]
We found lower grade in RP in 10% of total cases. 
Downgrading in Gleason score has been previously 
documented in literature, the percentage of cases 
varies from 5% to 82% [Table  1].[2,5,9,14] Similarly, 
in a meta-analysis, up to 7% downgrading had 
been reported.[14] Elabbady and Khedr made two 
groups in their study and compared TRUS-guided 
lateral sextant biopsy and TRUS 12-core biopsies. 
Former technique showed downgrading in 50% of 
cases while later technique showed downgrading 
in 14.8% of cases. This study concluded that the 
extended 12-core prostate biopsy is more reliable 
in both the detection of prostatic carcinoma and 
accuracy of Gleason score.[16] A Camtosun and 
Gökçe also mentioned that the reason of significant 
differences in Gleason score in TRUS and RP 
specimens became more obvious with increasing 
age, high PSA levels and decrease in prostate 
volume.[17]
RP Gleason score was concordant in 55% of our 
TRUS biopsy cases. Few studies also showed 
accurate prediction of Gleason score in 28.7–85.2% 
of the cases.[2,5,14,16] Reason of this wide variation 
in lack of Gleason score precision was attributed 
to lack of specialist expertise of pathologist and 
number of core biopsies.[5,16]
Bilateral tumour was initially detected in 44 out of 
100 cases. In 56 cases, tumour was found unilaterally 
in TRUS biopsies, but later 37 out of these showed 
bilateral prostate involvements. Hence, tumour 
upstaging was appreciated in RP specimen.[1] 
Tumour laterality discordance along with Gleason 
score tumour volume was also reported in some 
other studies when TRUS findings were compared 
with RP specimens.[5] Four of our cases also showed 
upstaging due to bilateral tumour out of 10 cases 
with unilateral tumour reporting on TRUS biopsy.
PNI is assessed routinely in TRUS biopsies and is 
relatively reproducible. Detection of perineural 
invasion does not require the use of any other 
ancillary technique. It is defined as prostate cancer 
around the nerve within perineural space. PNI is 
an important mechanism of spread of prostatic 
carcinoma in periprostatic tissue. Its detection in 
RP specimen has no significance; however, if it is 
found in TRUS biopsies then may alter treatment 
plan. This issue has been a matter of debate for a 
Table 1: Summary of prior literature examining the 
change in gradation of tumour between radical 
prostatectomy specimens and TRUS biopsies
Study Percentage of 
cases that were 
upgraded
Percentage of 
cases that were 
downgraded
Present study 35 10
Evan et al. 
(2016)[5]
31.5 14.3
Moon et al. 
(2010)[13]
53 -
Cohen et al. 
(2008)[14]
36 5
Zam et al. 
(2008)[9]
27 8
Cam et al. 
(2002)[2]
71.7 81.8
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significant period.[18] Many studies have associated 
it with extraprostatic extension and seminal vesicle 
invasion.[19] Multivariate analysis also showed similar 
findings.[19] There are few studies which did not find 
such association. Vargas et al. concluded that PNI 
is not an independent predictor of extraprostatic 
extension when PSA levels were included. O’Malley 
et al. were also unable to demonstrate that its 
detection of TRUS influences long-term tumour-
free survival.[20] We observed that 7 cases had EPE 
out of 10 cases which showed PNI.
In addition to the above-mentioned reasons for 
discrepancy in findings between TRUS and RP 
specimens, handling of radical specimens by 
different pathologists may be a reason. As some 
of the specimens were entirely submitted while 
in other cases, only representative sections were 
examined. Few centres are currently processing 
RP specimens, so few histopathologists are actually 
well versed with fine details of reporting. However, 
there is a hope that with the introduction of grade 
grouping and with increasing number of specimens 
in good institutions and with adequate training, the 
concordance between the specimens will improve 
in future.
There were differences observed in Gleason 
Grade between TRUS and RP. Nonetheless, TRUS 
biopsies appear to have the potential to aid in 
further management of the patients with prostate 
adenocarcinoma. This minimal invasive technique 
may help in establishing diagnosis and treatment 
planning in regions where the access to RP is 
limited. Additional studies are recommended to 
establish sensitivity and specificity of TRUS and to 
determine overall benefits of the Grade grouping.
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